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Cyclin E is often overexpressed in cancer tissue, leading to genetic instability and aneuploidy. Cullin 3 (Cul3)
is a component of the BTB-Cul3-Rbx1 (BCR) ubiquitin ligase that is involved in the turnover of cyclin E.
Here we show that liver-specific ablation of Cul3 in mice results in the persistence and massive expansion of
hepatic progenitor cells. Upon induction of differentiation, Cul3-deficient progenitor cells underwent substantial DNA damage in vivo and in vitro, thereby triggering the activation of a cellular senescence response
that selectively blocked the expansion of the differentiated offspring. Positive selection of undifferentiated
progenitor cells required the expression of the tumor suppressor protein p53. Simultaneous loss of Cul3 and
p53 in hepatic progenitors turned these cells into highly malignant tumor-initiating cells that formed largely
undifferentiated tumors in nude mice. In addition, loss of Cul3 and p53 led to the formation of primary
hepatocellular carcinomas. Importantly, loss of Cul3 expression was also detected in a large series of human
liver cancers and correlated directly with tumor de-differentiation. The expression of Cul3 during hepatic
differentiation therefore safeguards against the formation of progenitor cells that carry a great potential for
transformation into tumor-initiating cells.
Introduction
A genetic alteration frequently observed in cancer tissue is the
increased expression of cyclin E (1). For example, the majority
of liver cancers express this protein at levels higher than in the
surrounding normal tissue (2). Intriguingly, cyclin E is also able
to induce DNA double-strand breaks, which may lead to genetic
instability and aneuploid cells (3). Consistent with the importance of cyclin E in regulating cell proliferation and genetic stability, its expression levels are tightly controlled. In addition to
transcriptional mechanisms, cyclin E levels are also regulated
by posttranslational modifications that trigger the proteolytic
degradation of cyclin E by cullin 1– or cullin 3–dependent (Cul1or Cul3-dependent) ubiquitin ligases. Degradation of cyclin E by
the Cul1-dependent ubiquitin ligase requires its interaction with
the F-box protein Fbw7, which upon phosphorylation of cyclin E
at T380 by GSK3 and T384 by cdk2 tightly binds to the protein
and mediates its polyubiquitination and subsequent proteasomal
turnover (4, 5). Mutations in Fbw7 have been shown to induce
genetic instability, and certain types of human cancers such as
T cell leukemias and cholangiocellular carcinomas frequently
show alterations in this gene (6).
Loss of Fbw7 also affects stem cell proliferation by depleting
hematopoietic stem cells due to active cell cycling and an increase
in the rate of apoptotic cell death (7–9). Conversely, expression of a
stabilized version of cyclin E that can no longer be degraded by the
Fbw7-dependent E3 ubiquitin ligase results in an expansion of the
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pool of proliferating erythroid progenitors with a reduced ability
to differentiate and an increase in the rate of apoptosis (10). These
results point to a tissue-specific function of cyclin E turnover in
the maintenance of stem cell homeostasis.
In addition to the Cul1-dependent degradation system, a
second ubiquitylation complex that employs Cul3 is required
for the turnover of cyclin E (11). Cul3 forms a complex called
the BTB-Cul3-Rbx1 (BCR) ubiquitin ligase, which controls the
degradation of several proteins, including cyclin E, the meiotic
spindle formation factor Mei-1, the transcription factor Nrf2,
the Ci/Gli transcription factor, and the dishevelled protein in
the Wnt/β-catenin pathway (12–15). Loss of Cul3 in the mouse
leads to early embryonic lethality, with some cell types showing
increased levels of cyclin E (11). Ablation of Cul3 expression in
adult mouse hepatocytes in vivo results in a strong increase in
cell size and genetic instability in the Cul3-deficient liver cells
(16). While these results point to a central role of the BCR complex in maintaining cyclin E levels and cellular homeostasis,
nothing is known about the role of Cul3 in stem cells. We therefore ablated the Cul3 gene using an α-fetoprotein–Cre transgene
that induces Cre recombinase expression in the developing liver
starting at day 9.5 post coitum (p.c.).
In this work, we describe the phenotype of mice in which the
Cul3 gene was selectively deleted in liver tissue. We find that loss
of Cul3 leads to a massive expansion of liver progenitor cells that
undergo senescence upon induction of differentiation. This process depends on the expression of cyclin E, which in differentiating
cells induces DNA damage and subsequent activation of a p53dependent damage checkpoint. Simultaneous loss of p53 results
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in the formation of highly aggressive tumor-initiating cells, which
form hepatocellular carcinomas in situ and after transplantation.
Differentiation-induced senescence therefore constitutes a new
tumor suppressor mechanism in liver cells.
Results
Loss of Cul3 results in the accumulation of hepatic progenitor cells. To analyze
the function of the Cul3-based E3 ubiquitin ligase in liver embryogenesis, we crossed Cul3loxP/loxP mice with a transgenic mouse line
that expresses the Cre recombinase under the control of albumin
regulatory elements and α-fetoprotein enhancers (AlfpCre) (17),
which directs Cre recombinase expression to the liver starting at day
9.5 p.c. Mice were born at normal Mendelian ratios but only survived
until approximately 11 weeks after birth. Most Cul3loxP/loxP AlfpCre
mice were significantly smaller than their wild-type littermates, and
all of them showed an up to 30% decrease in body weight at the
time of death (data not shown). Upon macroscopic examination,
we found that the livers of Cul3loxP/loxP AlfpCre mice were larger and
appeared pale and of firm consistency (Figure 1A) compared with
wild-type control organs. Microscopic analysis of the liver tissue
and pathological findings revealed an almost complete loss of the
normal liver architecture, with a decrease in liver parenchyma and
areas of dysmorphic-appearing hepatocytes. These were surrounded
by small mononucleated cells of oval or round shape (Figure 1A),
which formed strand-like areas of cells that traversed the liver tissue. In addition, we detected a strong increase in connective tissue
(Supplemental Figure 1A; supplemental material available online
with this article; doi:10.1172/JCI41959DS1), which contributed to
the increase in consistency of the Cul3loxP/loxP AlfpCre livers. None of
these changes were observed in wild-type liver tissue. To differentiate Cul3-knockout cells from infiltrating stromal cells, lymphocytes,
and macrophages, which were all identified on histological examination of the liver tissue, we generated triple transgenic mice by
crossing Cul3loxP/loxP AlfpCre mice to β-galactosidase reporter mice
(Rosa26-LacZ). Given that Cre recombinase expression is under the
control of albumin regulatory elements and α-fetoprotein enhancers, LacZ expression should only be detectable in cells of hepatic origin. As shown in Figure 1B, β-galactosidase activity was detectable
in the small mononucleated cells and in the remaining hepatocytes,
indicating that Cre-mediated activation of LacZ expression was successful in these cells in vivo. To further confirm that the activation
of the Cre recombinase led to the loss of Cul3, we performed Cul3
Western blot and immunofluorescence analyses of Cul3 expression
in primary liver tissues. While whole liver lysates showed a loss of
Cul3 at 4 weeks after birth, we could detect a small increase in protein levels from 4 to 8 weeks (Supplemental Figure 1C). We therefore
performed immunofluorescence stainings for the Cul3 protein and
found that Cul3 expression was undetectable in hepatocytes and in
the mononucleated cells (Supplemental Figure 1D). The increase
in Cul3 protein at 8 weeks was therefore caused by an increase in
stromal cells, as shown in Supplemental Figure 1A. In addition, we
used albumin staining to analyze whether albumin is also expressed
in these small mononucleated cells. Using spleen as a negative control (Supplemental Figure 1B), we show that the AlfpCre transgene
is only active in the small mononucleated cells and in hepatocytes,
indicating that the cells in which Cul3 had been deleted were of
hepatic origin (Figure 1A).
Our histological examination suggested that the population of
small albumin-expressing cells in the Cul3-knockout livers might
constitute undifferentiated hepatic progenitor cells that had

expanded in number upon loss of Cul3. To determine the identity
of these cells, we used a panel of antibodies directed against surface epitopes frequently found on liver progenitor cells (18, 19).
We found that the small mononucleated cells in the Cul3-knockout livers were to varying degrees positive for CK14, CD133, or
CD34 expression (Figure 1C), pointing to an increase in the number of progenitor cells in Cul3-knockout livers as compared with
wild-type organs. These stainings were confirmed by Western blot
analysis of whole liver lysates in which the same stem cell markers
could also be detected (Supplemental Figure 2A).
Activation of the liver stem cell pool is frequently found under
conditions in which liver cell proliferation is blocked (20). Under
such conditions, a population of bipotential liver progenitor cells
called oval cells expands and differentiates into mature hepatocytes
to restore liver function (21). However, when we compared tissue
sections from 4- and 8-week-old livers, we detected a reduction in
the number of hepatocytes (Figure 1D) in the Cul3-knockout mice.
We used β-catenin to stain the plasma membrane of these cells,
which showed features typical of hepatocytes, thereby allowing us
to distinguish them from the small mononucleated cells (Supplemental Figure 1E). In contrast to the hepatocytes, the number of
cells expressing the stem cell markers CD34 and CD133 increased
over time (Figure 1E), while the CK14-positive cells did not. Our
analysis therefore shows that loss of Cul3 in liver tissue results in
a massive expansion of the pool of liver progenitor cells that fail to
adequately differentiate into mature hepatocytes.
Loss of Cul3 causes DNA damage in differentiated liver cells but not in
hepatic precursors. Next we analyzed why loss of Cul3 results in a
block of cellular differentiation. Cul3 had previously been shown
to regulate the stability of cyclin E (11). We therefore measured the
expression level of cyclin E and found it to be strongly increased in
Cul3loxP/loxP AlfpCre as compared with Cul3loxP/loxP liver cells (Figure
2A). In addition to cyclin E, we found the levels of Aurora B kinase,
another known Cul3 substrate (22), and of the cyclin kinase inhibitor p21 to be increased in these livers. Importantly, cyclin E levels
in Cul3-deficient livers were much higher than what we observed
under conditions of liver regeneration, in which up to 90% of all
hepatocytes synchronously entered the cell cycle, indicating that the
increased expression of cyclin E in Cul3-deficient livers is not simply
the result of increased cell proliferation (Supplemental Figure 2B).
Overexpression of cyclin E has been shown to induce DNA damage (3, 23), which can activate a p53-dependent checkpoint (24).
To quantitate the extent to which progenitor cells and differentiated cells undergo DNA damage in response to the loss of Cul3 in
vivo, we determined the levels of Ser139 phosphorylated histone
H2AX (γ-H2AX), a marker for DNA double-strand breaks in livers
from Cul3loxP/loxP AlfpCre mice, in wild-type livers and in livers
expressing only the Cre recombinase, as embryonic fibroblasts
from such mice were shown to display signs of DNA damage as a
result of Cre recombinase expression (25). As shown in Figure 2B,
γ-H2AX expression was detectable only in Cul3-deficient livers but
not in wild-type livers or in mouse livers that express only the Cre
recombinase. To confirm these results, we also performed Western
blot analyses, as shown in Supplemental Figure 2C. We then performed costainings of stem cell markers and γ-H2AX to identify
the cell type that showed the highest levels of DNA damage. For
these experiments, 100 cells from 3–4 mice of each age group were
scored. As shown in Figure 2C, only 20% of the CD34-positive cells
showed signs of DNA damage, while up to 70% of hepatocytes were
positive for γ-H2AX. CK14-positive cells that had maintained the
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Figure 1
Loss of Cul3 leads to accumulation of hepatic progenitor cells in the
liver. (A) Livers from Cul3loxP/loxP AlfpCre mice were harvested at 4
and 8 weeks after birth. The livers showed a pale discoloration and
firm consistency. Upon microscopic analysis, hepatocytes could be
distinguished from small mononucleated cells. Arrow indicates small
mononucleated cells in strands (compare inset) that surround hepatocytic fields. (B) LacZ stainings in Cul3loxP/loxP AlfpCre Rosa26-LacZ
mice were used to analyze the functionality of the Cre recombinase.
Scale bars: 50 μm; 20 μm (insets). (C) Immunofluorescence and
immunohistochemical detection of progenitor-associated surface
markers CK14, CD34 (first and third columns), and CD133. In wildtype livers, CK14-positive cells are primarily localized around bile ducts
(compare arrows). CD34- and CD133-positive cells can only be found
in Cul3-knockout livers (compare arrows that indicate positive cells in
the strands). Cells also expressed the hepatocyte marker albumin. In
the albumin staining, arrows indicate small mononucleated cells in the
strands positive for albumin. Images in the second and fourth columns
display the Dapi staining of the respective areas. Scale bars: 10 μm
(top panels); 50 μm (bottom panels). (D) Quantification of hepatocytes
in livers from Cul3loxP/loxP AlfpCre mice. H&E sections and β-catenin
stainings (compare Supplemental Figure 1E) were used to quantitate
the number of hepatocytes in the livers. For each quantification, 3–4
mice were analyzed. (E) Quantification of progenitor cells positive for
CD34, CD133, and CK14 at 4 and 8 weeks after birth. For each quantification, 3–4 mice were analyzed. **P < 0.005.

small oval-shaped morphology (Figure 2D) showed intermediate
levels of γ-H2AX positivity. In contrast, CK14-positive cells that
were larger and more resembled liver cells accumulated DNA damage to the same extent as hepatocytes.
DNA damage can result in cellular responses such as apoptosis or
cellular senescence (26, 27). In contrast to previous reports in which
loss of the Fbw7 protein or stabilization of cyclin E resulted in a significant increase in apoptotic cell death (7, 10), we failed to detect
increased numbers of apoptotic cells in Cul3loxP/loxP AlfpCre livers
(data not shown) and therefore tested whether these cells might
undergo senescence instead. As shown in Figure 2E, we found that
Cul3loxP/loxP AlfpCre mice show strongly elevated levels of p16ink4a
and p15ink4b at 4 and 8 weeks after birth as compared with wildtype mice. In line with our finding that loss of Cul3 leads to DNA
damage in differentiated cells, we found that CD34-positive cells
were largely negative for the expression of the senescence associated
marker p16, indicating that these cells are not affected by the loss
of Cul3 (Figure 2F) and therefore did not undergo senescence in
vivo. Together these results suggest that loss of Cul3 results in DNA
damage in differentiated hepatocytes, which ultimately undergo
senescence, while CD34-positive liver progenitor cells retain their
proliferative potential and expand in number over time.
Induction of differentiation induces senescence and cell cycle exit in
Cul3-deficient progenitor cells. To further analyze the relationship
between senescence and differentiation in Cul3-deficient cells, we
isolated Cul3-knockout cells from livers of Cul3loxP/loxP AlfpCre
mice (see Methods for details). As shown in Supplemental Figure 3A, a shortened fragment (Δ3–7) of the genomic Cul3 gene, in
which exons 3–7 of the Cul3 gene were deleted, can be detected by
RT-PCR in these cell lines. The isolated cell lines expressed the same
stem cell markers as those detected in the Cul3loxP/loxP AlfpCre livers from which they originated (Supplemental Figure 3B). Because
the CD34-positive fraction retained its proliferation capacity in
vivo, we analyzed these CD34-positive cells in more detail. For this
we separated the CD34-positive fraction from CD34-negative cells

by cell sorting and determined the expression of different surface
markers. As shown in Supplemental Figure 3C, CD34-positive cells
were positive for c-kit and CK14 and expressed AFP, albumin, and
the shortened version of the Cul3 transcript Cul3 Δ3–7. These cells
are negative for CD133 and express CK19 at low levels. To date,
we have derived a total of 5 independent Cul3-knockout lines and
have maintained them in culture for more than 12 months.
Using these cell lines, we established an in vitro differentiation
system to analyze the molecular mechanism involved in this process
in isolated progenitor cells. For this, we treated Cul3-knockout cells
with medium supplemented with different growth factors known
to induce hepatic differentiation in vitro (28). As shown in Figure
3A, asynchronously growing Cul3-knockout cells expressed CD34
and AFP, indicative of their precursor status. Upon treatment with
differentiation medium, both markers were no longer detectable
by RT-PCR, while at the same time Cul3-knockout cells started to
induce the expression of genes associated with hepatocellular differentiation. The hepatocyte-specific transcription factor PXR (29)
was strongly induced at 48 hours after cultivation in differentiation medium, followed by the induction of liver-specific transcription factors such as HNF1/4α and CCAAT enhancer binding protein α (C/EBPα) and albumin (30) (Figure 3A). Importantly, upon
differentiation, the vast majority of cells also changed their morphology from a small cell containing little cytoplasm to a cell that
showed the typical hepatocyte morphology and glycogen deposition (Supplemental Figure 4A) (31). Next we determined the percentage of cells staining positive for γ-H2AX in the differentiating
cells as compared with asynchronously growing Cul3-deficient
progenitor cells. As shown in Figure 3B, induction of differentiation led to a significant increase in the percentage of γ-H2AX–positive cells, while the number of proliferating cells as measured by
BrdU uptake was simultaneously decreasing (Figure 3C). In line
with the induction of senescence in Cul3-deficient livers in vivo, we
found that 96 hours after the induction of differentiation, Cul3deficient cells ceased to proliferate and entered a senescent state as
measured by β-galactosidase stainings, p15ink4b and p16ink4a induction (Figure 3D and Supplemental Figure 4B), and accumulation
of p53 (Supplemental Figure 4C). Given that the liver progenitor
cells that we describe here only arise in Cul3-knockout livers, we
decided to reconstitute Cul3 expression in the undifferentiated
Cul3-deficient cells. Supplemental Figure 4, D and E, show that
upon induction of differentiation, these cells do not accumulate
DNA damage, nor do they become senescence.
Interestingly, we found that CD34 expression was reaccumulating at 72–96 hours after the induction of differentiation (Figure
3A), while expression of other stem cell markers such as CK14,
c-kit, and CD133 decreased within this time course (Supplemental Figure 4F). To understand the reasons for the reaccumulation of CD34-positive cells, we pulse-labeled the cultures with
BrdU and performed double labelings for BrdU and CD34. Upon
induction of differentiation, we found a strong decrease in the
number of CD34-positive cells that took up BrdU. Approximately 99% of the whole stem cell population was differentiating,
and just a small fraction of CD34-positive cells remained in the
cell cycle. At 72 hours and 96 hours, between 20% and 30% of the
CD34-positive cells had reentered S phase as measured by BrdU
uptake, which indicates that CD34-positive cells are able to
resist differentiation-induced senescence (Figure 3E). As shown
in Figure 3F, these reaccumulating CD34-positive cells did not
show signs of DNA damage.
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Figure 2
Differentiation of Cul3-knockout
hepatic progenitor cells leads to the
induction of DNA damage and cellular
senescence. (A) Western blot analysis of known Cul3 substrates cyclin E,
Aurora B, and p21 at 4 and 8 weeks
after birth. Arrow indicates the cyclin
E band. Actin was used as a loading
control and was performed as noted in
the methods section. Noncontiguous
lanes from the same blot were spliced.
Numbers indicate the different mice
analyzed. (B) Immunofluorescence
staining of γ-H2AX in Cul3-knockout
and wild-type mice positive and negative for Cre recombinase. Arrows in
Cul3loxP/loxP AlfpCre (Cul3 KO) livers
indicate cells that accumulated DNA
damage. In wild-type Cre+ and Cre–
livers, no γ-H2AX (left panels) staining
can be detected (compare Supplemental Figure 2C). DAPI staining is shown
in the right panels. (C) Quantification
of DNA damage in CD34-, CD133-,
and CK14-positive cells (at least 100
cells from 3–4 mice were analyzed).
The graph shows quantification of
double-positive cells. (D) Representative pictures of round- and oval-shaped
CK14-positive cells (left panels). DAPI
is shown in the right panels. CK14positive cells cannot be found in wildtype livers. (E) Western blot analysis
for senescence-associated markers
p15 and p16 in whole liver lysates in
Cul3loxP/loxP AlfpCre livers at 4 and 8
weeks after birth in comparison with
wild-type liver lysates, in which no p15
or p16 could be detected. Numbers
indicate the different mice analyzed.
Noncontiguous lanes from the same
blot were spliced. (F) Quantification of
the expression of p16 in different liver
cells at 4 and 8 weeks (200 CD34- or
CK14-positive cells in 3 independent
experiments). Hepatocytes were identified by typical morphology (Supplemental Figure 1E). Scale bars: 10 μm.
*P < 0.05, **P < 0.005.

These in vitro findings therefore recapitulate our observation in
the Cul3-knockout mice in vivo, namely that CD34-positive Cul3deficient cells are resistant to the differentiation-induced DNA damage that forces the remainder of the population into senescence.
Cyclin E turnover is differentially regulated in liver progenitor cells and
hepatocytes. Cyclin E turnover requires the activity of the BCR ubiquitin
ligase. Our results regarding the induction of DNA damage in
differentiated cells but not in hepatic progenitor cells suggested
that the dependency on Cul3 activity depends on the differ
entiation stage of the cell. We therefore determined the half-life
of cyclin E in asynchronously growing cells and compared it with
the half-life of cyclin E in differentiating Cul3-deficient cells.
As shown in Figure 4A, cyclin E had a half-life of approximately
3824

5 hours in asynchronously proliferating cells, while 24 hours after
induction of differentiation, cyclin E was no longer degraded. In
contrast, reexpression of Cul3 resulted in normal degradation of
cyclin E (Supplemental Figure 4G), leading to a decrease in overall
cyclin E levels after 48 hours of differentiation (Supplemental Figure 4E). This indicates that the loss of Cul3 prevents the turnover
of cyclin E specifically in differentiating cells.
As asynchronously growing Cul3-deficient cells showed no signs
of DNA damage, we wondered whether these cells might be resistant
to cyclin E–induced DNA damage or might not be able to respond
to genotoxic stress altogether. However, after transfecting Cul3deficient cells with a cyclin E–expressing plasmid, we detected signs
of DNA damage (γ-H2AX positivity) in the cyclin E–overexpressing
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Figure 3
In vitro differentiation of progenitor cells recapitulates the in vivo phenotype. (A) RT-PCR analysis of progenitor cell– and hepatocyte-specific
markers in asynchronous (as) cells and at different time points during differentiation (Diff.). Noncontiguous lanes from the same gel were
spliced. (B) Quantitation of γ-H2AX staining by immunofluorescence at the indicated time points after the induction of differentiation. At least 3
independent experiments were analyzed. Asynchronously growing cells were set as 100%. (C) Quantitation of cells in S phase by BrdU uptake
(experiments were performed in triplicate). (D) Hepatic progenitor cells induce senescence upon differentiation. Western blot analysis during
differentiation shows a strong accumulation of the senescence-associated marker p15. Progenitor cells from Cul3 loxP/loxP AlfpCre mice stain positive for β-galactosidase at pH 5.8 at 96 hours after the induction of differentiation. All experiments were repeated 3–4 times. Actin was used as
a loading control and analysis performed as noted in Methods. Noncontiguous lanes from the same blot were spliced. (E) Analysis of proliferation of CD34-positive cells during differentiation by quantification of CD34/BrdU. Proliferation of CD34-positive cells in asynchronously growing
culture is also shown (n = 2). (F) Immunofluorescence γ-H2AX staining of CD34-positive cells at 96 hours of differentiation. Squares indicate
CD34-positive cells, showing that these do not accumulate DNA damage. Scale bars: 50 μm. *P < 0.05, **P < 0.005.

Cul3-negative cells (Figure 4B). We were also able to induce DNA
damage and phosphorylation of Chk1 when we treated Cul3knockout progenitor cells with the DNA-damaging agent H2O2 in
vitro (Figure 4C) or injected Cul3loxP/loxP AlfpCre mice with doxorubicin (Supplemental Figure 5A), indicating that DNA damage
response mechanisms are intact in Cul3-deficient progenitor cells.
These data suggested that the activity of the Cul3-dependent BCR
E3 ligase is dispensable in progenitor cells but that cyclin E levels
still need to be tightly controlled. We therefore wondered whether
loss of the FBW7-dependent Skp1, Cullin1, F-box protein contain-

ing complex (SCFFBW7) E3 ubiquitin ligase might affect cyclin E
levels and genetic stability in these cell lines. Knockdown of Fbw7
or Cul1, components of the Fbw7-dependent SCF complex in asynchronously growing Cul3-deficient cells, led to a complete stabilization of cyclin E (Figure 4D). The knockdown was confirmed by
RT-PCR (Figure 4E). Importantly, these cells also showed signs of
DNA damage upon loss of Fbw7 or Cul1 (Figure 4F). To determine
whether the accumulation of cyclin E was indeed responsible for the
observed induction of DNA damage, we transfected Cul3-deficient
progenitor cells with siRNAs targeting cyclin E1 and cyclin E2 and
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Figure 4
Accumulation of cyclin E in differentiating hepatic progenitor cells is responsible for the accumulation of DNA damage. (A) Cyclin E half-lives during
differentiation and in asynchronously proliferating cells. At 24 hours of differentiation, cyclin E accumulates (experiments were performed in triplicate). (B) Overexpression of myc-tagged cyclin E in asynchronously growing cells from Cul3loxP/loxP AlfpCre mice and quantitation of DNA damage
(γ-H2AX). Immunofluorescence for myc tagged (MT)-cyclin E, γ-H2AX, and DAPI. Arrows indicate cyclin E–overexpressing cell positive for γ-H2AX
(pink arrow) and an untransfected cell (white arrow) (n = 3). (C) Treatment of cells from Cul3loxP/loxP AlfpCre mice with H2O2 and analysis of DNA
damage by γ-H2AX and pChk1 Western blots. (D) Measurement of cyclin E half-lives upon siRNA-mediated knockdown of Fbw7 and Cul1 in asynchronously proliferating cells. Loss of Fbw7 and Cul1 increases cyclin E protein stability (n = 3/experiment). CHX, cycloheximide. (E) Confirmation
of siRNA-mediated knockdown by RT-PCR. GAPDH was used as control. Noncontiguous lanes from the same gel were spliced. (F) Increased DNA
damage as measured by γ-H2AX staining upon knockdown of Fbw7 and Cul1. For identification of transfected cells, a labeled siRNA control was
cotransfected. (G) siRNA-mediated knockdown of cyclin E during differentiation and determination of DNA damage (γ-H2AX). Knockdown of cyclin
E was confirmed by Western blotting. The arrow indicates the cyclin E band. c., scrambled siRNA control. Actin was used as a loading control and
analysis performed as noted in Methods. Noncontiguous lanes from the same blot were spliced. The graph shows quantification of γ-H2AX–positive cells transfected with the indicated siRNAs 96 hours after the induction of differentiation (n = 3). (H) RT-PCR analysis of Fbw7 and Cul3 Δ3–7
expression during differentiation of progenitor cells into hepatocytes at indicated time points. GAPDH was used as a control. *P < 0.05.

determined the number of γ-H2AX–positive cells. The knockdown
of the cyclin E protein was confirmed by Western blotting. While
differentiating Cul3-knockout cells still underwent DNA damage,
we found that knockdown of cyclin E led to a significant reduction
in the number of cells showing DNA damage as compared with
untransfected controls (Figure 4G). Our data suggest that loss of
Cul3 in progenitor cells is not sufficient to induce cyclin E–dependent DNA damage or interfere with the ability of liver progenitor
cells to self-renew. These undifferentiated cells nevertheless need
to control cyclin E stability through the activity of the SCFFbw7 E3
3826

ubiquitin ligase. However, upon induction of differentiation, Cul3
activity becomes critical, which then forces the Cul3-deficient cells
to activate their DNA damage response and exit the cell cycle. These
results suggested that the SCFFbw7 E3 ubiquitin ligase and the BCR
ubiquitin ligase must be differentially regulated in liver progenitor and differentiating cells. In line with this conclusion, we found
that Fbw7 transcripts are strongly downregulated in differentiating liver progenitor cells (Figure 4H). Fbw7 expression decreases
significantly between 12 and 24 hours of differentiation (compare
also Supplemental Figure 5B). Conversely, the shortened message
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Figure 5
Maintenance of senescence by p53
is essential for preventing the generation of tumor-initiating stem cells.
(A) Quantitation of p16 expression in the indicated liver cells from
Cul3/p53 double-knockout animals
at 10–11 weeks after birth. Values
are shown as difference relative
to p16-positive cells in livers from
Cul3 single-knockout animals
(compare Figure 2F) (n = 3/group).
(B) Quantitation of γ-H2AX expression in the indicated liver cells from
Cul3/p53 double knockout animals
at 10–11 weeks after birth. Values
are shown as difference relative
to γ-H2AX–positive cells in livers
from Cul3 single-knockout animals
(compare Figure 2C) (n = 3/group).
(C) Quantitation of γ-H2AX staining
by immunofluorescence at the indicated time points after the induction
of differentiation. Asynchronously
growing cells were set as 100%.
(D) Quantitation of S-phase cells by
BrdU uptake at the indicated time
points after the induction of differentiation. (E) Comparative genomic
hybridization analysis of Cul3 and
Cul3/p53 double-knockout cells
after induction of differentiation for
96 hours compared with undifferentiated cells of the identical genotype.
*P < 0.05, **P < 0.005.

derived from the deleted Cul3 locus (Cul3 Δ3–7) is constitutively
expressed under these conditions (Figure 4H) and declined only to
about 60% but then remained constant (compare also Supplemental Figure 5B). In accordance with the downregulation of Fbw7, we
found Cul1, the E3 ligase component for the F-box protein Fbw7,
also to be downregulated between 48 and 96 hours of differentiation (Supplemental Figure 5C).
The loss of Cul3 therefore becomes critical only under conditions of cellular differentiation, at which point the differentiated cells are undergoing DNA damage–induced senescence. We
therefore next asked whether the inactivation of the DNA damage response pathway might convert the Cul3 deficient nontumorigenic progenitor cells into tumor cells.

Loss of p53 collaborates with Cul3 deficiency to induce highly malignant
tumor stem cells. The p53 protein is an important regulator of cellular senescence and is also frequently mutated in human liver
cell cancers (32). To analyze its role in the differentiation-induced
senescence pathway, we crossed the Cul3loxP/loxP AlfpCre mice to
a p53loxP/loxP mouse strain (33). As shown in Supplemental Figure 6A, Cul3/p53loxP/loxP AlfpCre double-knockout livers showed
similar changes in liver architecture: residual hepatocytes and an
accumulation of small mononucleated cells expressing the same
markers as Cul3loxP/loxP AlfpCre livers (Supplemental Figure 6, B,
D, and E). To test whether the induction of senescence observed
in the Cul3-deficient livers is dependent on the expression of p53,
we measured the expression of p16ink4a in primary liver tissue
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Figure 6
Loss of p53 in Cul3-knockout progenitor cells leads to generation of tumor-initiating cells in vivo. (A) Transplantation of Cul3-knockout and
Cul3/p53-knockout progenitor cells into nude mice. Shown is the average of 6 tumors from 3 mice after injection of 1 × 106 cells. P values for the
increase in tumor size were calculated using the t test and are as follows: d 31/d 41, P = 0.0034; d 31/d 39, P = 0.744; d 39/d 48, P = 0.0022.
(B) H&E staining of tumors derived from nude mice. CK14 and CD34 (bottom left panels) immunofluorescence staining to identify cells with
stem cell characteristics. The bottom right panels show DAPI staining. Scale bars: 50 μm. (C) Primary hepatocellular tumors arise in Cul3/p53
double-knockout livers (area indicated by arrow), while no tumors can be found in Cul3-knockout livers. For comparison, WT livers are shown.
Scale bars: 200 μm. (D) Analysis of Cul3 and cyclin E protein levels in normal human liver tissue (nt) and hepatocellular carcinoma (HCC-G3) by
immunohistochemistry. Original magnification, ×40. (E) HCC tissues show a strong downregulation of Cul3 and induction of cyclin E expression
as measured by immunohistochemistry in normal human liver, dysplastic nodes, and hepatocellular cancers. De-differentiation of tumors correlated with the decrease in Cul3 protein (r = –0.375; P = 0.0001). Expression ranges from 0 (no expression) to 3 (strong expression). Increase
in cyclin E protein levels and decrease in Cul3 protein levels correlated significantly upon de-differentiation of tumors (r = –0.476; P = 0.046).

from Cul3/p53 double-knockout mice. In contrast to Cul3 singleknockout livers, we found significantly fewer CK14-positive cells
that showed p16ink4a expression in the Cul3/p53 double-knockout livers (Figure 5A), while p16ink4a levels were not significantly
different in CD34-positive progenitor cells or hepatocytes. As
p21 also accumulated in these livers (Supplemental Figure 6C),
we concluded that its expression depends on the induction of
DNA damage but is independent of p53. To further analyze the
3828

proliferative potential of these different cell types, we treated the
Cul3/p53loxP/loxP AlfpCre mice with CCl4 to induce liver regeneration. As shown in Supplemental Figure 6F, only the CK14-positive cells showed a significant increase in BrdU uptake when compared with CK14-positive cells in CCl4-untreated Cul3/p53loxP/loxP
AlfpCre livers. These findings therefore indicate that the loss of p53
results in decreased p16 expression in Cul3-negative, CK14-positive
cells, which thereby retain their proliferative potential in vivo.
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We did, however, detect a strong increase in the number of CK14
cells that stained positive for γ-H2AX (Figure 5B). In line with
these in vivo results, we found that isolated Cul3/p53 doubleknockout progenitor cells showed signs of DNA damage (Figure
5C) upon induction of differentiation (Supplemental Figure 5D)
but in contrast to Cul3 single-knockout cells failed to exit the cell
cycle, as shown in Figure 5D. Together these results indicate that
induction of p53 prevents cell cycle progression in differentiating Cul3-deficient CK14-positive progenitor cells and forces these
cells into senescence.
To further substantiate these findings with regard to the formation of human liver cancers, we tested the role of Cul3 in the prevention of DNA damage and the induction of senescence markers
in human liver cancer cell lines. As shown in Supplemental Figure
7A, a reduction in the expression of Cul3 in HepG2 cells through
siRNA treatment led to an increase in the number of CD133-positive cells of about 25%. Loss of Cul3 was confirmed by RT-PCR
(Supplemental Figure 7B). Moreover, asynchronously growing human CD133-positive cells in which Cul3 expression was
decreased by siRNA treatment showed an increase in the S-phase
fraction as measured by BrdU uptake when compared with control
siRNA–treated CD133-positive cells (Supplemental Figure 7A).
HepG2 cells started to express liver differentiation markers
such as HNF4α when treated with differentiation medium (Supplemental Figure 7C), while at the same time expression levels of
Fbw7 were decreasing and expression levels of Cul3 were increasing. Next we tested whether loss of Cul3 during differentiation
would lead to the induction of DNA damage as measured by
the expression of γ-H2AX and induction of senescence markers. Supplemental Figure 7D shows that Cul3-deficient human
cells indeed undergo DNA damage and start to express p15 after
induction of differentiation.
As our studies in Cul3-deficient mouse liver progenitor cells suggested that differentiation-induced DNA damage and senescence
lead to the activation of a p53-dependent DNA damage response,
we compared CD133-positive cells derived from a p53-positive
(HepG2) cell line with CD133-positive cells that express a mutant
version of p53 (HUH7). As shown in Supplemental Figure 7, E and F,
only the p53 wild-type CD133-positive cells ceased to proliferate
after the induction of differentiation, while p53 mutant CD133positive cells continued to take up BrdU. Together these findings
support our finding derived from the study of Cul3-deficient
mouse liver progenitor cells, namely that the expression of Cul3
is required to prevent the formation of genetically unstable cells
after the induction of differentiation.
Genetic instability is a hallmark of liver cancer development
and increases as the tumor de-differentiates (34). To test whether
the observed induction of double-strand breaks in differentiating
Cul3-deficient hepatocytes would lead to the formation of genetically unstable cells, we performed comparative genomic hybridization analysis in Cul3 single- and Cul3/p53 double-knockout
cells and compared their genetic composition before and after
the induction of differentiation. Figure 5E shows that while Cul3knockout cells remained genetically stable, loss of p53 resulted in
the induction of multiple chromosomal rearrangements as early
as 96 hours after the induction of differentiation.
Cul3 is expressed at low levels in hepatocellular carcinomas. Our data
show that loss of Cul3 predisposes hepatic progenitor cells to
the induction of DNA damage. However, the induction of a p53dependent senescence mechanism blocks the proliferation of

such cells, which limits their tumorigenic potential. In line with
this conclusion, we found that Cul3-deficient hepatic progenitor
cells fail to form tumors in nude mice, as shown in Figure 6A. We
found that in contrast to the Cul3 single-knockout cells, all of
the Cul3/p53 double-knockout lines we isolated formed tumors
after transplantation into nude mice (Figure 6A). Importantly, as
few as 100 Cul3/p53 double-knockout progenitor cells were sufficient to form tumors (700–800 mm3), with a latency of approximately 70 days. Remarkably, the tumors generated by these cells
did not grow in a confined position under the skin of the mouse,
but often also infiltrated into the supporting muscle layers and
into the peritoneal cavity.
Upon histological examination, we found highly malignant anaplastic tumors displaying variable aspects of hepatic and cholangiocytic development (Figure 6B). Immunohistochemical analysis
revealed cells that were positive for CD34 but also large areas that
did not stain for this marker, indicating the differentiation potential of the Cul3/p53 double-knockout cells from which the tumor
originated. Next we tested whether loss of p53 in a Cul3-deficient
mouse liver would also result in the formation of primary liver cell
carcinomas. Microscopic examination of the Cul3/p53 doubleknockout livers at 11 weeks after birth revealed the presence of
hepatocellular carcinomas in these mice, while none of the Cul3
single-knockout mice developed liver tumors during their life span
(Figure 6C). It is, however, important to note that the overall life
span of the Cul3/p53 double-knockout mice was not different
from that of the Cul3-knockout mice, indicating that the severe
disruption of liver architecture was most likely responsible for the
death of these animals and prevented the formation of large, macroscopically visible liver cancers.
Based on our findings in the Cul3 mouse model, we asked
whether loss of Cul3 expression might also contribute to liver
carcinogenesis in humans. We therefore analyzed the expression
levels of Cul3 in normal human liver tissue (n = 42), dysplastic
liver nodes (n = 9), and malignant human liver cancers (n = 62).
Given the importance of cyclin E dysregulation for the observed
phenotypes in our mouse model, we also stained these tissues
with antibodies specific for cyclin E. A representative example of
these immunohistochemical stainings is shown in Figure 6D. A
quantification of the results of this analysis is shown in Figure
6E, in which Cul3 expression levels were assigned scores ranging from 0 (no expression) to 3 (strong expression). This analysis
revealed that in contrast to normal liver tissue or dysplastic nodes,
tumor tissues expressed greatly reduced levels of Cul3 (r = –0.375;
P = 0.0001). Conversely the expression levels of cyclin E were very
low in normal liver tissue but significantly increased in tumor tissues. Moreover, the increase in cyclin E protein levels and decrease
in Cul3 protein levels correlated significantly upon de-differentiation of tumors (r = –0.476, P = 0.046). Finally, we tested whether
the observed correlation between Cul3 expression and differentiation was specific to hepatocellular carcinomas or whether similar
changes could be observed in cholangiocellular carcinomas as
well. For this we analyzed Cul3 expression in cholangiocellular
carcinomas using 67 CCC G2 and 84 CCC G3 tumors. In contrast
to hepatocellular carcinomas, expression levels of Cul3 did not
correlate with the de-differentiation process in cholangiocellular
carcinomas when compared with Cul3 expression levels of normal cholangiocytes or of normal liver tissue (Supplemental Figure 6G). The role of Cul3 in tumorigenesis of the liver therefore
seems to be restricted to hepatocellular carcinomas.
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Discussion
In this work we provide a mechanistic framework for explaining how highly malignant liver cancers can arise from liver stem
cells. We tested the importance of reduced Cul3 expression for
liver tumorigenesis in a mouse model that allows the tissue-specific ablation of the Cul3 gene. Using this model system, we show
that loss of the Cul3-based degradation system has two important effects that promote the generation of liver tumors. First, it
prevents the development of mature hepatocytes from hepatic
progenitor cells. It is important to note that the block to differentiation we observe in Cul3-deficient cells is not caused by a
defect in a differentiation pathway but is instead a result of the
activation of DNA damage response mechanisms specifically in
differentiating but not in progenitor cells. Due to the existence
of a redundant cyclin E ubiquitin ligase, the SCFFbw7 complex,
progenitor cells are protected from the DNA damage–inducing
activity of cyclin E accumulation. This difference in sensitivity to
loss of Cul3 and therefore induction of DNA damage positively
selects for the expansion of immature progenitor cells but drives
differentiating cells into senescence. Nevertheless, this mechanism
would arrest the development of Cul3-deficient progenitor cells
by negatively selecting against the differentiated offspring. It is
also interesting to note that while both cyclin E ubiquitylation
complexes are expressed in undifferentiated mouse liver progenitor cells, only the SCFFbw7 system is required for cyclin E turnover
in these cells. Upon induction of differentiation toward mature
hepatocytes, Fbw7 expression is transcriptionally downregulated.
It is unknown why during liver cell differentiation a switch between
the Fbw7- and the Cul3-dependent degradation systems occurs or
which transcription factors might influence the expression of the
Fbw7 gene. However, dual regulation of a substrate by SCF and
Cul3-dependent degradation systems is not without example, as
recent work demonstrates that the transcription factor cubitus
interruptus, which is the downstream target of Hedgehog signaling, is degraded by SCFSlimb/beta-TRCP and a Cul3-HIB–dependent E3
ubiquitin ligases (13, 35). Interestingly, in eye imaginal discs, where
Hedgehog signals coordinate cell proliferation and differentiation,
the BTB protein HIB is highly expressed in the differentiating cells
to prevent aberrant Hedgehog signaling activity and ensure normal eye development (35).
In addition to the differential effect the loss of Cul3 has on the
induction of genetic damage in progenitor versus differentiated
cells, its expression is critical for the ability of the differentiating
cell to proliferate. In this work we show that after induction of
differentiation, CD34-positive Cul3-deficient cells rapidly cease
to proliferate and undergo senescence in vitro. This response
depends on the induction of the p53 tumor suppressor protein. As
we were unable to identify liver cancers in Cul3-deficient mouse
livers or after transplantation of Cul3-deficient cells into nude
mice, we conclude that the differentiation-induced senescence
checkpoint efficiently protects from the development of liver
cancer. However, loss of p53 is one of the most frequent genetic
defects identified in human hepatocellular carcinomas (32). Specifically, long-standing liver inflammation, aflatoxin intoxication,
and viral hepatitis–associated liver cancer are frequently associated with defects in the p53 tumor suppressor protein. We therefore tested whether the loss of Cul3 in hepatic progenitors would
synergize with loss of p53 in the induction of hepatocellular carcinoma. Indeed, we found that loss of p53 completely abrogated
the differentiation-induced senescence response of Cul3-deficient
3830

hepatic progenitors. Alternatively, Cul3/p53-deficient progenitor
cells could undergo senescence in response to DNA damage but
then due to the loss of p53 escape the senescence response and
reenter the cell cycle. Our in vitro data, however, do not argue
for such a mechanism, as in contrast to the Cul3-deficient cells,
the Cul3/p53 double-knockout cells did not exit the cell cycle in
response to the induction of differentiation. It is interesting to
note that the induction of p21 is most likely not responsible for
the observed cell cycle arrest in Cul3-deficient cells, as the Cul/p53
double-knockout cells also showed increased levels of p21. The
connection between the p53- and the p15/p16-dependent signaling pathways therefore seems to be responsible for the observed
changes in proliferation in the different mouse lines.
Importantly, not only did the Cul3/p53-deficient cells lose their
ability to undergo cell cycle arrest, they also displayed severe chromosomal alterations that were detectable as early as 96 hours after
the induction of differentiation. Loss of p53 in differentiating
Cul3-deficient progenitor cells therefore promotes the formation
of highly malignant genetically unstable cancer cells. These cells
display several features of cancer-initiating cells. After transplantation into nude mice, they form tumors at very low cell numbers. As
few as 100 Cul3/p53-deficient cells were sufficient to form cancers
in this model and were serially transplantable. Histological and
immunohistochemical analysis of these tumors revealed highly
pleomorphic tumors, which in addition to containing tumor cells
that showed features of hepatocytic differentiation also contained
the CD34-positive progenitor cells from which they originated.
Expansion of the number of liver progenitor cells that then differentiate into mature hepatocytes is best characterized in animal
models in which normal liver cell proliferation is blocked (36).
Under such conditions, bipotential liver progenitor cells will
expand in number and help to repopulate the damaged organ.
This continuous proliferation will ultimately exhaust the regenerative potential of the mature hepatocytes and thus induce a compensatory expansion of progenitor cells that attempt to replace
damaged liver cells. We hypothesize that Cul3-deficient hepatic
progenitor cells reside in the liver over a long period of time but
only attempt to expand and differentiate into hepatocytes when
the regenerative capacity of the liver is exhausted. Therefore, only
when hepatocyte-based liver regeneration is sufficiently impaired
do liver progenitor cells receive sufficient external signals to
undergo differentiation. While liver cirrhosis is known to be a
prerequisite for the formation of genetically altered hepatocytes
that ultimately give rise to tumors, it might also be necessary for
the formation of stem cell–derived liver cancers. This idea could
explain why most liver cancers, even those with histologic features
of stem cells, originate from cirrhotic livers.
The model that arises from our study predicts that defects such
as the loss of Cul3 will lead to severe genetic damage in differentiated cells but not in progenitor cells from which these cells originate. This difference is based on the differential expression of the
SCFFbw7 and Cul3-BTB dependent ubiquitin ligases and selects for
the expansion of undifferentiated progenitor cells while the differentiated offspring undergo senescence. Cul3-deficient progenitor
cells can persist in the liver only in their undifferentiated state but
carry a high risk of malignant transformation. A second genetic
alteration, such as the loss of p53, which is essential for maintaining the senescence response activated by the loss of Cul3 in differentiated cells, is sufficient to transform these cells into highly
malignant tumor-initiating cells. In summary, our data provide
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the framework for the identification of genes that by connecting
differentiation and DNA damage responses in stem or progenitor
cells allow for the formation of tumor-initiating cells.
Methods
Mouse work and tumor studies. All experiments were performed with the
approval of the animal rights and protection agencies Niedersächsisches
Landesamt für Verbraucherschutz und Lebensmittelsicherheit, Lower
Saxony, Germany. Livers of Cul3loxP/loxP AlfpCre and Cul3/p53loxP/loxP AlfpCre mice were harvested at 4 and 8 weeks after birth. DNA, RNA, and
protein extractions were done as previously described (37). Tumor studies
were done as previously described (38). Tumor growth was determined for
6 tumors of 3 mice for each genotype. To determine the minimum number
of cells able to form a tumor in nude mice, Cul3/p53 hepatic progenitor
cells were serially diluted to 100 cells per injection.
To analyze liver regeneration, we mixed CCl4 1:4 with mineral oil and
injected 3.5 μl/g mouse intraperitoneally. After 48 hours, BrdU was injected 2 hours before sacrifice. Livers were harvested and fixed in PFA. Staining
was performed as described below.
To analyze DNA damage responses of CD34-positive cells in Cul3loxP/loxP
AlfpCre mice, we injected mice with doxorubicin (0.01 μg/g mouse). After
48 hours, livers were harvested and fixed in PFA. Stainings were done as
described below. Goldner staining was used to identify stromal cells.
Statistics. All statistical analyses were done using Prism software (GraphPad)
(2-tailed t test). All graphs were created using Microsoft Excel software, and
error bars were calculated with Excel. All data are represented as mean ± SD.
Western blot analysis. Tissue or liver lysates were generated as described previously (39). The protein concentration of all lysates was determined using
the Bradford method (Bio-Rad) according to the manufacturer’s instructions. Samples were aliquoted, shock frozen in liquid nitrogen, and stored at
–80°C. A test gel probed for actin was run to ensure correct quantification of
protein concentrations. If necessary, protein concentrations were readjusted
and determined again by the Bradford method and controlled by Western
blotting using an actin-specific antibody. These aliquoted lysates were used
for further analyses with specific antibodies. To ensure equal transfer of proteins, gels were stained with Coomassie blue after blotting and membranes
were analyzed with ink or Ponceau staining after exposure to the film.
Antibodies used for Western blotting were cyclin E (Delta Biolabs), actin
(ICN), p21 (Santa Cruz Biotechnology Inc.), p16 (Biozol), ICAM1 (Abcam),
Aurora B (Abcam), pChk1, p15 (Cell Signaling Technology), Cul3 (Santa
Cruz Biotechnology Inc.), PKM2 (US Biological), CK14 (Progen), CD34
(BioLegend), and CD133 (Abcam, 19898). Secondary antibodies were purchased from Amersham.
Immunofluorescence staining/tissue array. Immunofluorescence staining
of paraffin sections was performed using the following antibodies: CK14
(Progen), CD34 (BioLegend), CD133 (Abcam, 19898), albumin (Acris),
γ-H2AX (Upstate, clone JBW301), and p16 (Biozol, LS-C32847).
Stainings of paraffin sections were done as described below.
CK14 staining: Antigen unmasking was performed in Tris/EDTA buffer,
pH 9.0, for 20 minutes. Slides were allowed to cool down slowly at room
temperature. Sections were permeabilized in 0.3% Triton for 2 minutes
and washed in PBS. Primary antibody was diluted 1:150 and incubated
overnight at 4°C. Slides were washed in PBS, and secondary antibody was
incubated for 1 hour at room temperature at a dilution of 1:400.
CD34 staining: Antigen unmasking was performed in Tris/EDTA buffer,
pH 9.0, for 20 minutes. Slides were allowed to cool down slowly at room
temperature. Sections were permeabilized in 0.3% Triton for 2 minutes,
washed in PBS, and incubated with primary antibody (1:50) overnight at
4°C. Slides were washed, and secondary antibody was used at a 1:100 dilution for 1 hour at room temperature.

CD133 staining: Antigen unmasking was performed in citrate buffer,
pH 6.0, for 20 minutes. Slides were allowed to cool down slowly at room
temperature. Antibody was incubated overnight at a dilution of 1:50. After
washing in PBS, secondary antibody was incubated at a 1:100 dilution for
1 hour at room temperature.
Cul3 staining: Antigen unmasking was performed in Tris/EDTA buffer,
pH 9.0, for 20 minutes. Slides were allowed to cool down slowly at room
temperature. Sections were permeabilized in 0.3% Triton for 2 minutes and
washed in PBS. Endogenous peroxidase was blocked in 0.3% H202 for 20
minutes. All other steps were done following the instructions of the TSA
Kit (PerkinElmer). In short, unspecific binding was blocked using the TNB
Buffer as described in the kit. Cul3 antibody (Santa Cruz Biotechnology Inc.,
H293) was diluted 1:100 and incubated overnight at 4°C. Secondary antibody (anti-rabbi–biotin [Dianova]) was incubated for 1 hour at room temperature after the slides were properly washed in PBS. After washing, Streptavidin-Peroxidase was used as supplied with the TSA kit (Perkin Elmer) and
incubated for 1 hour. Fluorescence substrate was incubated for 5 minutes,
and after washing slides were counterstained with DAPI and mounted.
γ-H2AX, p16 costaining: Antigen retrieval was performed in 10 mM citrate
buffer (for γ-H2AX costainings) or in Tris/EDTA buffer, pH 9.0 (p16 costainings). Unspecific binding was minimized by incubation of sections with 1%
BSA or by using MOM blocking reagent (Vector). Quantitation of cells was
done on 3 different sections of at least 3 mice. Stem cell markers were analyzed as described above.
BrdU staining: For BrdU staining, slides were deparaffinized and antigen unmasking was performed in Tris/EDTA buffer. Double staining was
performed using the Amersham Proliferation kit and CD34 and CK14
antibodies.
For immunofluorescence detection of DNA damage of cells grown on
coverslips, the Abcam antibody ab11174 was used. Cells were fixed in 4%
PFA at the indicated time points for 3 minutes, washed in PBS, and permeabilized in 0.1% Triton for 5 minutes. Antibody incubation was done
after blocking in 1% BSA/PBS for 1 hour. To analyze proliferation, the Cell
Proliferation Kit (Amersham) was used according to the manufacturer’s
instructions. Secondary antibodies for immunofluorescence were purchased from Dianova. For quantitation of DNA damage and BrdU uptake,
3 independent experiments were analyzed. All statistical analyses were
done using the t test and Prism 5 statistics software.
Tissue microarray analysis of human normal tissue and HCC as well as
statistical analysis have been described previously (40). The following scoring system was used to represent quantity: 0, no expression; 1, positivity in
less than 1% of tumor cells; 2, positivity in 1%–9% of tumor cells; 3, positivity in 10%–50% of tumor cells; 4, positivity in more than 50% of tumor cells.
Antibodies used for Cul3 staining and cyclin E were purchased from Acris
(HE12) and Delta Biolabs (C19).
LacZ staining. Cryosections were fixed in fixing solution (0.2% glutaraldehyde, 50 mM EGTA, pH 7.3, 100 mM MgCl2 in PBS). Staining was performed overnight in staining buffer (0.5 mg/ml X-gal, 5 mM potassium
ferrocyanide, 5 mM potassium ferricyanide in 2 mM MgCl2, 0.01% sodium
deoxycholate, 0.02% Nonidet P40 in PBS; pH 7.3). The next day, section
were washed in PBS, counterstained with hemalaun, and covered in Kaiser’s glycerogelatin. All pictures were taken with a DM5000B microscope
(Leica) using the DFC300FX camera and Leica software.
Isolation of hepatic progenitor cells. Cells were isolated by chopping fresh
mouse liver tissue in media containing 10% FCS. Supernatant and small
liver pieces were transferred to a 10-cm culture dish and cultivated overnight. The next day, half of the medium (5 ml) was replaced with fresh medium. Cells were cultivated for 2–3 months, with half of the medium replaced
every 3–4 days, until the plate was confluent. Cell lines were subjected to
single clone expansion for RT-PCR and differentiation into hepatocytes.
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Differentiation of hepatic progenitor cells. Differentiation medium was prepared
as described previously (28). The medium was further supplemented with 2%
FCS and 40 ng/ml HGF (Sigma-Aldrich) and 20 ng/ml EGF (Sigma-Aldrich).
For differentiation experiments, cells were seeded in 12-well plates coated with
collagen (1 mg/ml; Roche) at a density of 3.2 × 104 cells/well. For analysis of
cells by FACS sorting, CD34 staining was performed on living cells. Anti–rat
Cy3 secondary antibody was used. Purity of sorted cells was 90%.
Differentiation of HepG2 and HUH7 cells was achieved by plating cells
on collagen-coated plates. HGF, EGF, and dexamethasone were added to
the medium.
siRNA knockdown of cyclin E1 and E2, FBW7, Cul1, and Cul3. The following
siRNA molecules were purchased from Ambion: ccne1 ID 161045; ccne2 ID
600056; Cul1: ID 70723; Cul3: ID 16050. Fbw7 knock down was achieved
by using 3 different siRNAs targeting Fbw 7.
siRNA was transfected at a final concentration of 10 nM. Transfections
were done according to the instructions for use (HiPerFect, QIAGEN).
For identification of transfected cells, a labeled control siRNA was transfected simultaneously. Transfection efficiency was approximately 90%. The
knockdown was confirmed by RT-PCR using Fbw7 and Cul1 primers (see
below for sequences).
For determination of cyclin E half-lives, transfection was done in asynchronously proliferating cells 24 hours after seeding. Cycloheximide was
added (final concentration, 10 mg/ml) 72 hours after seeding the cells.
Samples were taken at the time points indicated. Western blot analysis was
done for cyclin E, and protein bands were quantified using Bio-Rad Quantification software (Quantity One).
HepG2 and HUH7 cells were transfected after seeding on a 6-cm plate
using 20 nM Cul3 siRNA. After 48 hours, cells were labeled with BrdU for
12 hours and then trypsinized for FACS analysis.
FACS analysis. HUH7 and HepG2 cells were transfected with siRNA and harvested after 60 hours. Cells were resuspended in 1% BSA, 1 mM EDTA in PBS,
and Cd133 was stained using BD antibody 130-080-801. Cells were washed
twice at 4°C and fixed using the BD Cytofix/Cytoperm Solution provided
with the BrdU FITC Kit (51-2354AK). Analysis was done using FACSCalibur.
Transfection of progenitor cells. Cells were seeded at a density of 4 × 104 cells
per well, which contained gelatin-coated coverslips. The next day, cells were
transfected with Attractene from QIAGEN following the instructions for
use. Twenty-four hours later, coverslips were fixed in PFA for 3 minutes
and stained using myc-tag-specific antibody (Upstate).
Cul3 reconstitution. Cul3-knockout clones were transfected with linearized
pCS2 Cul3 plasmid and the selection plasmid pBabe Puro using Polyfect
transfection reagent according to the manufacturer’s protocol (Qiagen).
Cells were selected with 2 μg/ml puromycin, and clones were selected for
further analysis by Western blotting for Cul3.
Treatment with H2O2. Cells were seeded at a density of 4 × 104 cells per well
on gelatin-coated coverslips. H2O2was added at a concentration of 350 μM.
Cells were harvested 30 minutes after addition of H2O2 and analyzed by
Western blotting.
cDNA synthesis and PCR. RNA extractions were done as previously
described (37). Primers used to monitor differentiation of progenitor
cells into hepatocytes were: HNF1α (29) dioxygenase, GST, CD34, Thy1
(41), albumin and AFP (42), PXR (43), and c-kit (44). Primers used to
amplify C/EBPα and HNF4α were as follows: C/EBPα forward 5′-AAAGC1. Malumbres M, Barbacid M. To cycle or not to cycle:
a critical decision in cancer. Nat Rev Cancer. 2001;
1(3):222–231.
2. Masaki T, et al. Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma
versus cirrhosis. Hepatology. 2003;37(3):534–543.
3. Spruck CH, Won KA, Reed SI. Deregulated
cyclin E induces chromosome instability. Nature.
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CAAGAAGTCGGTGGA-3′ and C/EBPα reverse, 5′-CAGTTCACGGCTCAGCTGTT-3′. HNF4α forward, 5′-CTTCCTTCTTCATGCCAG-3′ and
HNF4α reverse, 5′-ACACGTCCCCATCTGAAG-3′. Primers used to analyze expression of p15 and p16 were as follows: p16 forward, 5′-CCGCTGCAGACAGACTGGC-3′; p16 reverse, 5′-TGAGGCCGGATTTAGCTCTG-3′;
p15 forward, 5′-AGATCCCAACGCCCT-3′; p15 reverse, 5′-AGATCCCAACGCCCT-3′. Primers for p21 were published previously (45).
Primers used for expression analysis of Fbw7 and Cul3 (wild-type and
deleted version) were as follows: Fbw7 forward, 5′-CAAATCTCCTAAGGTGCTGAAAGGGCATG-3′ and reverse, 5′-ccacatggatgccatcaaactgtaatgaatag-3′; Cul3 forward, 5′-ATAAATAAGGTGCGAGAAGAT-3′ and reverse, 5′-AGTCAAAGGGCTAACAGAAC-3′. For
Cul3, PCR products were gel purified and sequenced by Agowa to confirm
deletion of the Cul3 fragment.
Primers used to amplify human Cul3 were 5′-ATGACCATGGATGAAAAATATG-3′ and 5′-CAATATTGTTTCTACTTCTTGTTCTG-3′. Cul1
primers to analyze knockdown upon siRNA treatment were Cul1 forward,
5′-CAAATCTTCTTAAGGATGGAGAAGATTTAATG-3′ and Cul1 reverse,
5′-CAGCCCCAATTCCACATAAGATTG-3′.
PAS staining and β-galactosidase staining. Cells grown on coverslips were
fixed in 4% PFA for 3 minutes, washed in PBS, and subjected to permeabilization in 0.1% Triton for 10 minutes. Cells were then washed in distilled water and treated with 1% periodic acid for 5 minutes. Cells were
extensively washed with distilled water and incubated in Schiff reagent for
10 minutes. After cells were washed with tap water, they were mounted in
gelatin. To confirm specific staining of glycogen after permeabilization, we
treated cells with 5 mg/ml diastase for 30 minutes at 37°C.
Senescence-associated β-galactosidase activity was analyzed by incubating cells in freshly prepared staining solution (1 mg/ml 5-bromo-4 chloro3-indolyl β-d galactosidase in DMF/40 mM citric acid (pH 5.8), 5 mM
potassium ferrocyanide, 5 mM potassium ferricyanide, 150 mM NaCl, and
2 mM MgCl2). Cells were incubated at 37°C for 24 hours.
Array comparative genomic hybridization. Array comparative genomic
hybridization was performed using Agilent Mouse Genome Microarray Kit
244A (Agilent Technologies), a high-resolution 60-mer oligonucleotidebased microarray with median probe spacing of about 6.4 kb. Labeling and
hybridization of genomic DNA were performed according to the protocol
provided by Agilent.

Acknowledgments
We thank Sarah Messnard for expert technical assistance. We also
thank Holly Sundberg Malek, Arnaud Besson, James M. Roberts,
Lars Zender, and Lenhard Rudolph for critical advice. This work
was supported by grants from Deutsche Krebshilfe (Max Eder Program) and Deutsche Forschungsgemeinschaft to N.P. Malek.
Received for publication December 7, 2009, and accepted in revised
form July 21, 2010.
Address correspondence to: Nisar P. Malek, Hannover Medical School, Carl Neuberg Strasse 1, 30625 Hannover, Germany.
Phone: 01149.511.532.4585; Fax: 01149.511.532.428; E-mail:
Malek.Nisar@MH-Hannover.de.

1999;401(6750):297–300.
4. Welcker M, Clurman BE. FBW7 ubiquitin ligase: a
tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer.
2008;8(2):83–93.
5. Strohmaier H, Spruck CH, Kaiser P, Won KA, Sangfelt O, Reed SI. Human F-box protein hCdc4 targets
cyclin E for proteolysis and is mutated in a breast

cancer cell line. Nature. 2001;413(6853):316–322.
6. Akhoondi S, et al. FBXW7/hCDC4 is a general
tumor suppressor in human cancer. Cancer Res.
2007;67(19):9006–9012.
7. Onoyama I, et al. Conditional inactivation of
Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis. J Exp
Med. 2007;204(12):2875–2888.

The Journal of Clinical Investigation    http://www.jci.org    Volume 120    Number 11    November 2010

research article
8. Matsuoka S, et al. Fbxw7 acts as a critical fail-safe
against premature loss of hematopoietic stem
cells and development of T-ALL. Genes Dev. 2008;
22(8):986–991.
9. Thompson BJ, et al. Control of hematopoietic stem
cell quiescence by the E3 ubiquitin ligase Fbw7.
J Exp Med. 2008;205(6):1395–1408.
10. Minella AC, et al. Cyclin E phosphorylation regulates
cell proliferation in hematopoietic and epithelial lineages in vivo. Genes Dev. 2008;22(12):1677–1689.
11. Singer JD, Gurian-West M, Clurman B, Roberts JM.
Cullin-3 targets cyclin E for ubiquitination and
controls S phase in mammalian cells. Genes Dev.
1999;13(18):2375–2387.
12. Pintard L, et al. The BTB protein MEL-26 is a substrate-specific adaptor of the CUL-3 ubiquitinligase. Nature. 2003;425(6955):311–316.
13. Zhang Q, Zhang L, Wang B, Ou CY, Chien CT,
Jiang J. A hedgehog-induced BTB protein modulates hedgehog signaling by degrading Ci/Gli transcription factor. Dev Cell. 2006;10(6):719–729.
14. Zhang DD, Lo SC, Cross JV, Templeton DJ, Hannink M. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase
complex. Mol Cell Biol. 2004;24(24):10941–10953.
15. Angers S, et al. The KLHL12-Cullin-3 ubiquitin
ligase negatively regulates the Wnt-beta-catenin
pathway by targeting Dishevelled for degradation.
Nat Cell Biol. 2006;8(4):348–357.
16. McEvoy JD, Kossatz U, Malek N, Singer JD. Constitutive turnover of cyclin E by Cul3 maintains
quiescence. Mol Cell Biol. 2007;27(10):3651–3666.
17. Kellendonk C, Opherk C, Anlag K, Schutz G, Tronche
F. Hepatocyte-specific expression of Cre recombinase. Genesis. 2000;26(2):151–153.
18. Mishra L, et al. Liver stem cells and hepatocellular
carcinoma. Hepatology. 2009;49(1):318–329.
19. Lemaigre F, Zaret KS. Liver development update: new
embryo models, cell lineage control, and morphogenesis. Curr Opin Genet Dev. 2004;14(5):582–590.
20. Libbrecht L, Roskams T. Hepatic progenitor
cells in human liver diseases. Semin Cell Dev Biol.
2002;13(6):389–396.
21. Duncan AW, Dorrell C, Grompe M. Stem cells
and liver regeneration. Gastroenterology. 2009;

137(2):466–481.
22. Sumara I, et al. A Cul3-based E3 ligase removes
Aurora B from mitotic chromosomes, regulating
mitotic progression and completion of cytokinesis
in human cells. Dev Cell. 2007;12(6):887–900.
23. Bartkova J, et al. Oncogene-induced senescence is part
of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature. 2006;444(7119):633–637.
24. Loeb KR, et al. A mouse model for cyclin E-dependent genetic instability and tumorigenesis. Cancer
Cell. 2005;8(1):35–47.
25. Loonstra A, et al. Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells.
Proc Natl Acad Sci U S A. 2001;98(16):9209–9214.
26. Collado M, Blasco MA, Serrano M. Cellular senescence in cancer and aging. Cell. 2007;130(2):223–233.
27. Halazonetis TD, Gorgoulis VG, Bartek J. An oncogene-induced DNA damage model for cancer development. Science. 2008;319(5868):1352–1355.
28. Block GD, et al. Population expansion, clonal
growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF,
EGF and TGF alpha in a chemically defined (HGM)
medium. J Cell Biol. 1996;132(6):1133–1149.
29. Li J, Ning G, Duncan SA. Mammalian hepatocyte
differentiation requires the transcription factor
HNF-4alpha. Genes Dev. 2000;14(4):464–474.
30. Costa RH, Kalinichenko VV, Holterman AX, Wang
X. Transcription factors in liver development, differentiation, and regeneration. Hepatology. 2003;
38(6):1331–1347.
31. Ishii K, et al. Hepatic differentiation of human
bone marrow-derived mesenchymal stem cells by
tetracycline-regulated hepatocyte nuclear factor
3beta. Hepatology. 2008;48(2):597–606.
32. Ozturk M. Genetic aspects of hepatocellular carcinogenesis. Semin Liver Dis. 1999;19(3):235–242.
33. Marino S, Vooijs M, van Der Gulden H, Jonkers J,
Berns A. Induction of medulloblastomas in p53null mutant mice by somatic inactivation of Rb in
the external granular layer cells of the cerebellum.
Genes Dev. 2000;14(8):994–1004.
34. Wilkens L, et al. Induction of aneuploidy by increasing chromosomal instability during dedifferentiation of hepatocellular carcinoma. Proc Natl Acad Sci

U S A. 2004;101(5):1309–1314.
35. Ou CY, Lin YF, Chen YJ, Chien CT. Distinct protein degradation mechanisms mediated by Cul1
and Cul3 controlling Ci stability in Drosophila eye
development. Genes Dev. 2002;16(18):2403–2414.
36. Roskams TA, Libbrecht L, Desmet VJ. Progenitor cells in diseased human liver. Semin Liver Dis.
2003;23(4):385–396.
37. Kossatz U, Dietrich N, Zender L, Buer J, Manns
MP, Malek NP. Skp2-dependent degradation of
p27kip1 is essential for cell cycle progression. Genes
Dev. 2004;18(21):2602–2607.
38. Nickeleit I, et al. Argyrin a reveals a critical role for
the tumor suppressor protein p27(kip1) in mediating antitumor activities in response to proteasome
inhibition. Cancer Cell. 2008;14(1):23–35.
39. Malek NP, Sundberg H, McGrew S, Nakayama
K, Kyriakides TR, Roberts JM. A mouse knock-in
model exposes sequential proteolytic pathways that
regulate p27Kip1 in G1 and S phase. Nature. 2001;
413(6853):323–327.
40. Singer S, et al. Protumorigenic overexpression of
stathmin/Op18 by gain-of-function mutation in
p53 in human hepatocarcinogenesis. Hepatology.
2007;46(3):759–768.
41. Suzuki A, et al. Clonal identification and characterization of self-renewing pluripotent stem
cells in the developing liver. J Cell Biol. 2002;
156(1):173–184.
42. Ogawa S, et al. Crucial roles of mesodermal cell
lineages in a murine embryonic stem cell-derived
in vitro liver organogenesis system. Stem Cells.
2005;23(7):903–913.
43. Xu DX, et al. Perinatal lipopolysaccharide exposure
downregulates pregnane X receptor and Cyp3a11
expression in fetal mouse liver. Toxicol Sci. 2005;
87(1):38–45.
44. Kotton DN, Fabian AJ, Mulligan RC. A novel
stem-cell population in adult liver with potent
hematopoietic-reconstitution activity. Blood. 2005;
106(5):1574–1580.
45. Ludtke TH, Christoffels VM, Petry M, Kispert A.
Tbx3 promotes liver bud expansion during mouse
development by suppression of cholangiocyte differentiation. Hepatology. 2009;49(3):969–978.

The Journal of Clinical Investigation    http://www.jci.org    Volume 120    Number 11    November 2010

3833

Copyright of Journal of Clinical Investigation is the property of American Society for Clinical Investigation and
its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's
express written permission. However, users may print, download, or email articles for individual use.

